Tumour Targeting with Rationally Modified Cell-Penetrating Peptides
- 27 June 2012
- journal article
- Published by Springer Nature in International Journal of Peptide Research and Therapeutics
- Vol. 18 (4), 361-371
- https://doi.org/10.1007/s10989-012-9312-1
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Homing peptides as targeted delivery vehiclesIntegrative Biology, 2010
- Assessing the uptake kinetics and internalization mechanisms of cell-penetrating peptides using a quenched fluorescence assayBiochimica et Biophysica Acta (BBA) - Biomembranes, 2010
- Predicting cell-penetrating peptidesAdvanced Drug Delivery Reviews, 2008
- Increased MMP‐2 activity during intervertebral disc degeneration is correlated to MMP‐14 levelsThe Journal of Pathology, 2008
- Studying the uptake of cell-penetrating peptidesNature Protocols, 2006
- Delivery of substances and their target-specific topical activationBiochimica et Biophysica Acta (BBA) - Biomembranes, 2006
- The possible role of matrix metalloproteinase (MMP)-2 and MMP-9 in cancer, e.g. acute leukemiaCritical Reviews in Oncology/Hematology, 2004
- Matrix Metalloproteinase Inhibitors and Cancer—Trials and TribulationsScience, 2002
- Matrix metalloproteinase expression by endothelial cells in collagen lattices changes during co-culture with fibroblasts and upon induction of decorin expressionJournal of Cellular Physiology, 2001
- Design of protecting groups for the β‐carboxylic group of aspartic acid that minimize base‐catalyzed aspartimide formationInternational Journal of Peptide and Protein Research, 1996